APLS APELLIS PHARMACEUTICALS INC

Ownership history in GROUP ONE TRADING LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which GROUP ONE TRADING LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2023 Q4)
Avg. % of fund
0.01%
First filed
2019 Q3
Last filed
2025 Q3
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 14,925 -1,853 -11.0% 0.00% $338K $22.63
2025 Q2 REDUCED 16,778 -13,263 -44.1% 0.00% $290K $17.31
2025 Q1 REDUCED 30,041 -12,112 -28.7% 0.00% $657K $21.87
2024 Q3 ADDED 42,153 +7,454 +21.5% 0.00% $1.2M $28.84
2024 Q2 REDUCED 34,699 -219,206 -86.3% 0.01% $1.3M $38.36
2023 Q4 ADDED 253,905 +27,221 +12.0% 0.04% $15.2M $59.86
2023 Q3 ADDED 226,684 +207,866 +1104.6% 0.03% $8.6M $38.04
2023 Q2 ADDED 18,818 +13,908 +283.3% 0.01% $1.7M $91.10
2023 Q1 REDUCED 4,910 -45,913 -90.3% 0.00% $324K $65.96
2022 Q4 ADDED 50,823 +25,000 +96.8% 0.01% $2.6M $51.71
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)
← Back to GROUP ONE TRADING LLC Holdings